Dr. Trifan joined Alpha-9 as CMO in January 2024, bringing over 20 years of experience in pharmaceutical clinical development. Prior to Alpha-9, he served as the Chief Medical Officer at Apexigen, TRexBio, and most recently Totus Medicines. Previous roles include positions in clinical development at Bristol-Myers Squibb, Onyx Therapeutics, Johnson & Johnson, and Pharmacia. Dr. Trifan holds an MD in Medicine and a PhD in Cell Biology from Carol Davila University in Bucharest, Romania.

• 

  Chief Medical Officer in Alpha-9 Oncology

  Harnessing the Power of Radiopharmaceuticals